Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer (Q38743961)
Jump to navigation
Jump to search
scientific article published on 05 June 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer |
scientific article published on 05 June 2017 |
Statements
1 reference
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer. (English)
1 reference
Jose Baselga
1 reference
Giuseppe Viale
1 reference
Denise A Yardley
1 reference
Marion Procter
1 reference
Gunter von Minckwitz
1 reference
Dimitrios Zardavas
1 reference
Mark Benyunes
1 reference
Thomas Suter
1 reference
Amal Arahmani
1 reference
Nathalie Rouchet
1 reference
Emma Clark
1 reference
Adam Knott
1 reference
Istvan Lang
1 reference
Jose Bines
1 reference
Richard D Gelber
1 reference
Martine Piccart
1 reference
APHINITY Steering Committee and Investigators
1 reference
5 June 2017
1 reference
1 reference
2 references